Walleye Trading’s Surmodics SRDX Stock Holding History

Walleye Trading’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-490	Closed	-$37K	–	5259
2018 Q3	$37K	Buy	+490	New	+$33.7K	﹤0.01%	4676
2016 Q3	–	Sell	-2,100	Closed	-$49K	–	5381
2016 Q2	$49K	Buy	+2,100	New	+$46K	﹤0.01%	4000

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Trading's SRDX Position: Q4 2018 in Review

Walleye Trading sold out of Surmodics (SRDX) in Q4 2018, closing a stake of 490 shares — an estimated $37K sold.

Walleye Trading first reported a position in SRDX in Q2 2016 and held it in 2 quarters. The position peaked at $49K in Q2 2016. 161 funds tracked by Wall St. Rank hold SRDX as of Q4 2018.

Walleye Trading reported no remaining Surmodics position as of Q4 2018 after selling out during the quarter.
Walleye Trading sold 490 Surmodics shares in Q4 2018, an estimated $37K.
Walleye Trading first reported a position in Surmodics in Q2 2016 and held it in 2 quarters.
Walleye Trading's Surmodics position peaked at $49K in Q2 2016.
161 funds tracked by Wall St. Rank held Surmodics as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.